Insider · CIK 0001490216
Francis M Cuss
Files at MURA (Mural Oncology plc). First filing -, latest -.
In brief
Francis M Cuss files SEC Form 4 as director at MURA (Mural Oncology plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Francis M Cuss has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -8,637 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -8,462 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -15,021 | - | - | 0 | Dec 5, 2025 |
| Jun 11, 2025 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +8,637 | $0.00 | $0 | 8,637 | Jun 13, 2025 |
Questions about Francis M Cuss
Answered from the filings on this page, as of the latest one.
Is Francis M Cuss buying or selling?
Francis M Cuss has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Francis M Cuss's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Francis M Cuss has 0.
Where does Francis M Cuss file Form 4?
Francis M Cuss has filed Form 4 at MURA (Mural Oncology plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.